KZR-261-101: KZR-261 in Subjects With Advanced Solid Malignancies (clinicaltrials.gov) - Dec 21, 2025 - P1 | N=61 | Terminated | Sponsor: Kezar Life Sciences, Inc. | Trial completion date: Dec 2026 ➔ Jan 2025 | Active, not recruiting ➔ Terminated | Trial primary completion date: Dec 2025 ➔ Jan 2025; Sponsor decision.
Trial completion date • Trial primary completion date • Trial termination • Colorectal Cancer • Melanoma • Oncology • Prostate Cancer • Solid Tumor
|